Since, I am working in the area of cancer nanotechnology; I am much interested on NCI activities for discovering new nanoparticulate drug delivery systems and characterization of these systems.
The relevant areas of focus that need to be addressed include:
•Formulation of nanoparticles in bulk scale
•Actual biodistribution of nanoparticles
•Toxicity of nanoparticles
(idea received by e-mail)